BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26849641)

  • 1. Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome.
    Aldámiz-Echevarría T; Berenguer J; Miralles P; Jiménez-Sousa MA; Carrero A; Pineda-Tenor D; Díez C; Tejerina F; Pérez-Latorre L; Bellón JM; Resino S
    PLoS One; 2016; 11(2):e0148537. PubMed ID: 26849641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.
    Berenguer J; Zamora FX; Aldámiz-Echevarría T; Von Wichmann MA; Crespo M; López-Aldeguer J; Carrero A; Montes M; Quereda C; Téllez MJ; Galindo MJ; Sanz J; Santos I; Guardiola JM; Barros C; Ortega E; Pulido F; Rubio R; Mallolas J; Tural C; Jusdado JJ; Pérez G; Díez C; Álvarez-Pellicer J; Esteban H; Bellón JM; González-García J;
    Clin Infect Dis; 2015 Mar; 60(6):950-8. PubMed ID: 25422386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.
    Sanmartin R; de Felipe E; Tor J; Sanvicens A; Barluenga E; Martinez E; Muga R; Jou A; Ojanguren I; López JJ; Clotet B; Tural C
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1235-43. PubMed ID: 22443303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients.
    de Castro IF; Micheloud D; Berenguer J; Guzmán-Fulgencio M; Catalán P; Miralles P; Alvarez E; López JC; Cosín J; Lorente R; Muñoz-Fernández MA; Resino S
    AIDS; 2010 Aug; 24(13):2059-67. PubMed ID: 20616694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.
    Sanmartín R; Tor J; Sanvisens A; López JJ; Jou A; Muga R; Ojanguren I; Barluenga E; Videla S; Planas R; Clotet B; Tural C
    HIV Med; 2014 Apr; 15(4):203-12. PubMed ID: 24245909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.
    Macías J; Márquez M; Téllez F; Merino D; Jiménez-Aguilar P; López-Cortés LF; Ortega E; von Wichmann MA; Rivero A; Mancebo M; Santos J; Pérez-Pérez M; Suárez-Lozano I; Romero-Palacios A; Torres-Cornejo A; Pineda JA
    Clin Infect Dis; 2013 Nov; 57(10):1401-8. PubMed ID: 23946224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies.
    Labarga P; Fernández-Montero JV; López M; Barreiro P; de Mendoza C; Sierra-Enguita R; Treviño A; Soriano V
    Antivir Ther; 2014; 19(8):799-803. PubMed ID: 24964405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in asymptomatic carriers of hepatitis C virus.
    Fukuda Y; Nakano I; Katano Y; Marui A; Hayakawa T
    J Int Med Res; 1998 Dec; 26(6):313-8. PubMed ID: 10399113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha.
    Lo Iacono O; García-Monzón C; Almasio P; García-Buey L; Craxí A; Moreno-Otero R
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1091-9. PubMed ID: 9845398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response.
    Casado JL; Esteban MA; Bañón S; Moreno A; Perez-Elías MJ; Mateos ML; Moreno S; Quereda C
    Dig Dis Sci; 2015 Nov; 60(11):3473-81. PubMed ID: 26112991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
    Mussini C; Lorenzini P; Puoti M; Lichtner M; Lapadula G; Di Giambenedetto S; Antinori A; Madeddu G; Cozzi-Lepri A; d'Arminio Monforte A; De Luca A;
    PLoS One; 2015; 10(12):e0140877. PubMed ID: 26640953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble adhesion molecule profiling in preoperative infants with biliary atresia.
    Davenport M; Gonde C; Narayanaswamy B; Mieli-Vergani G; Tredger JM
    J Pediatr Surg; 2005 Sep; 40(9):1464-9. PubMed ID: 16150350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hepatitis C virus infection on soluble cellular adhesion molecules in hemodialysis patients.
    Peng YS; Chiang CK; Hsu SP; Pai MF; Hung KY; Kao JH
    Blood Purif; 2005; 23(2):106-12. PubMed ID: 15640602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher serum levels of soluble intracellular cell adhesion molecule-1 and soluble vascular cell adhesion molecule predict peripheral artery disease in haemodialysis patients.
    Cheng CH; Chen YS; Shu KH; Chang HR; Chou MC
    Nephrology (Carlton); 2012 Nov; 17(8):718-24. PubMed ID: 22905988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosis Progression in Paired Liver Biopsies from HIV/HCV-Coinfected Patients without Prior Treatment of Hepatitis C.
    Leite AG; Duarte MI; Mendes-Correa MC
    J Int Assoc Provid AIDS Care; 2015; 14(5):463-8. PubMed ID: 26056147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of sICAM-1 and sVCAM-1 molecules for cardiac surgery in pediatric patients with pulmonary hypertension.
    Yıldırım A; Güzelmeriç F; Öner CN; Karaağaç AT; Şaşmazel A; Erdem H; Özdemir O; Baysal A
    Anadolu Kardiyol Derg; 2014 May; 14(3):274-9. PubMed ID: 24936542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy.
    Fernández-Montero JV; Barreiro P; Vispo E; Labarga P; Sánchez-Parra C; Soriano V
    AIDS; 2013 Apr; 27(7):1129-34. PubMed ID: 23276803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease.
    Pawlak K; Mysliwiec M; Pawlak D
    Clin Biochem; 2015 Apr; 48(6):425-30. PubMed ID: 25617664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of sICAM-1 and sVCAM-1 level with biochemical, histological and viral findings in chronic hepatitis C after interferon-alpha + ribavirin therapy.
    Radu C; Dejica D; Grigorescu M; Zaharie T; Neculoiu D
    Rom J Gastroenterol; 2003 Jun; 12(2):91-5. PubMed ID: 12853993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients.
    Labarga P; Fernandez-Montero JV; de Mendoza C; Barreiro P; Pinilla J; Soriano V
    Antivir Ther; 2015; 20(3):329-34. PubMed ID: 25372299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.